These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8663420)
21. AML1/Runx1 recruits calcineurin to regulate granulocyte macrophage colony-stimulating factor by Ets1 activation. Liu H; Holm M; Xie XQ; Wolf-Watz M; Grundström T J Biol Chem; 2004 Jul; 279(28):29398-408. PubMed ID: 15123671 [TBL] [Abstract][Full Text] [Related]
22. DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cells. Britos-Bray M; Sacchi N; Friedman AD Leukemia; 1996 Jun; 10(6):984-90. PubMed ID: 8667656 [TBL] [Abstract][Full Text] [Related]
23. Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells. Tanaka K; Tanaka T; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Hirai H Biochem Biophys Res Commun; 1995 Jun; 211(3):1023-30. PubMed ID: 7598688 [TBL] [Abstract][Full Text] [Related]
24. A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells. Zhang YW; Bae SC; Huang G; Fu YX; Lu J; Ahn MY; Kanno Y; Kanno T; Ito Y Mol Cell Biol; 1997 Jul; 17(7):4133-45. PubMed ID: 9199349 [TBL] [Abstract][Full Text] [Related]
25. Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain. Bae SC; Takahashi E; Zhang YW; Ogawa E; Shigesada K; Namba Y; Satake M; Ito Y Gene; 1995 Jul; 159(2):245-8. PubMed ID: 7622058 [TBL] [Abstract][Full Text] [Related]
26. Identification of redox-sensitive cysteines in GA-binding protein-alpha that regulate DNA binding and heterodimerization. Chinenov Y; Schmidt T; Yang XY; Martin ME J Biol Chem; 1998 Mar; 273(11):6203-9. PubMed ID: 9497343 [TBL] [Abstract][Full Text] [Related]
27. Leukemogenesis by the chromosomal translocations. Mitani K Leukemia; 1997 Apr; 11 Suppl 3():294-6. PubMed ID: 9209370 [TBL] [Abstract][Full Text] [Related]
28. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias. Lo Coco F; Pisegna S; Diverio D Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595 [TBL] [Abstract][Full Text] [Related]
29. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. Huang G; Shigesada K; Ito K; Wee HJ; Yokomizo T; Ito Y EMBO J; 2001 Feb; 20(4):723-33. PubMed ID: 11179217 [TBL] [Abstract][Full Text] [Related]
30. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Thirunavukkarasu K; Mahajan M; McLarren KW; Stifani S; Karsenty G Mol Cell Biol; 1998 Jul; 18(7):4197-208. PubMed ID: 9632804 [TBL] [Abstract][Full Text] [Related]
31. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence. Kurokawa M; Ogawa S; Tanaka T; Mitani K; Yazaki Y; Witte ON; Hirai H Oncogene; 1995 Sep; 11(5):833-40. PubMed ID: 7675444 [TBL] [Abstract][Full Text] [Related]
32. The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Tanaka T; Kurokawa M; Ueki K; Tanaka K; Imai Y; Mitani K; Okazaki K; Sagata N; Yazaki Y; Shibata Y; Kadowaki T; Hirai H Mol Cell Biol; 1996 Jul; 16(7):3967-79. PubMed ID: 8668214 [TBL] [Abstract][Full Text] [Related]
33. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Michaud J; Wu F; Osato M; Cottles GM; Yanagida M; Asou N; Shigesada K; Ito Y; Benson KF; Raskind WH; Rossier C; Antonarakis SE; Israels S; McNicol A; Weiss H; Horwitz M; Scott HS Blood; 2002 Feb; 99(4):1364-72. PubMed ID: 11830488 [TBL] [Abstract][Full Text] [Related]
34. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain. Nagata T; Werner MH J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761 [TBL] [Abstract][Full Text] [Related]
35. TLE, the human homolog of groucho, interacts with AML1 and acts as a repressor of AML1-induced transactivation. Imai Y; Kurokawa M; Tanaka K; Friedman AD; Ogawa S; Mitani K; Yazaki Y; Hirai H Biochem Biophys Res Commun; 1998 Nov; 252(3):582-9. PubMed ID: 9837750 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of core-binding factor alpha (CBF alpha) reverses cellular transformation by the CBF beta-smooth muscle myosin heavy chain chimeric oncoprotein. Hajra A; Liu PP; Speck NA; Collins FS Mol Cell Biol; 1995 Sep; 15(9):4980-9. PubMed ID: 7651416 [TBL] [Abstract][Full Text] [Related]
37. New mechanisms of AML1 gene alteration in hematological malignancies. Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654 [TBL] [Abstract][Full Text] [Related]
38. Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera. Huang G; Shigesada K; Wee HJ; Liu PP; Osato M; Ito Y Blood; 2004 Apr; 103(8):3200-7. PubMed ID: 15070703 [TBL] [Abstract][Full Text] [Related]
39. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Ogawa E; Maruyama M; Kagoshima H; Inuzuka M; Lu J; Satake M; Shigesada K; Ito Y Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6859-63. PubMed ID: 8341710 [TBL] [Abstract][Full Text] [Related]
40. Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Bae SC; Yamaguchi-Iwai Y; Ogawa E; Maruyama M; Inuzuka M; Kagoshima H; Shigesada K; Satake M; Ito Y Oncogene; 1993 Mar; 8(3):809-14. PubMed ID: 8437866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]